A recent phase III randomized trial found an investigational oral small-molecule GLP-1 receptor agonist significantly ...

Asian and Pacific Islander adolescents who are overweight or obese are twice as likely as their white peers to have ...

Study analyzing 77 research papers finds habitual consumption of processed foods increases chronic disease risk, challenging ...

Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the best NASDAQ growth stocks to buy for the next 3 years.

A new study found that Ozempic's main ingredient may treat people with type 1 diabetes, control blood sugar, and lose weight.

Type 2 diabetes remission and weight loss rates are significantly higher among adults who replace diet beverages with water.

Sana Biotechnology, Inc. (NASDAQ:SANA) ranks among the best CRISPR stocks to buy. On June 24, Citizens JMP reaffirmed its $5 ...

In summary, foot care is a vital part of managing type 2 diabetes. Simple steps like daily foot checks, gentle washing, ...

A study found that the newer generation of much more effective diabetes medications are reaching only a fraction of the ...

Cass Wheeler (left), who led the American Heart Association for over three decades, died recently at 84. In the center is ...

The highly competitive, $100,000 award supports mission-driven graduate students working toward a professional or advanced ...

The use of a smart speaker with preprogrammed diabetes care features may help older adults manage their diabetes and improve ...